Mar 14

Flashback:

SSRI Stories – Antidepressant Nightmares: School Shootings & Incidents (!)

SSRI Stories – Antidepressant Nightmares – ‘We Speak For The Dead To Protect The Living’

Making A Killing: The Untold Story Of Psychotropic Drugging (Full Documentary)


25 disturbing facts about psych drugs, soldiers and suicides (Natural News, March 14, 2013):

We are living in an age of upside-downs, where right is wrong, fiction is truth and war is peace. Those who fight the wars are subjected to their own house of mirrors via pharmaceutical “treatments.” Instead of providing U.S. soldiers and veterans with actual health care, the government throws pills at them and calls it “therapy.”

Stimulants, antidepressants, anti-psychotics, sedatives and pain meds are the new “fuel” for America’s front-line forces. While the idea of sending medicated soldiers into battle was unthinkable just three decades ago, today it’s the status quo. And the cost in human lives has never been more tragic. Continue reading »

Tags: , , , , , ,

Mar 17

big_pharma_drugs_money

Who is Patrick McGorry and what does he promote?  He’s a psychiatrist just named Australian of the Year for his work in “youth mental health reform.”  What does that reform consist of?  What he calls a “new form of climate change.” It sure is.

[See TIME Magazine Article “Drugs Before Diagnosis?”]

He not only promotes youths being put on antipsychotics and antidepressants, cited by international drug regulatory agencies as causing hallucinations, hostility, personality change, life-threatening diabetes, strokes, suicide and death, McGorry goes a giant step further-drug them before they’ve even developed a “psychiatric” disorder.

The Association for the Accreditation of Human Research Protection Programs (AHRPP) likens such concepts to “performing mastectomies on women who are at risk of-but do not have-breast cancer.”[i]

The UN Committee on the Rights of the Child has expressed “serious concerns” about child drugging and Senate investigations in the United States have found high profile psychiatrists who were pharmaceutically funded and using fraudulent research being among the heaviest promoters of psychiatric drug use on children. While the rest of the world is experiencing serious alarm at the rampant use of deadly psychiatric drugs on children, McGorry pushes full steam ahead to increase the amount of children being needlessly subjected to psychiatry’s most powerful drugs-antidepressants and antipsychotics.

His theory and practices are so controversial that even his colleagues in the United States have backed away from it.  And a parallel study done in the United States based on the same theory that McGorry uses was considered an abject failure-even by the investigators themselves.  Other psychiatrists have criticized McGorry’s pre-drugging practice as unethical and harmful to adolescents.  More on that later.

This is especially so as the “symptoms” McGorry and cohorts invented to “pre-label” youths as potential candidates for psychosis and “schizophrenia” (to start with) are, according to one U.S. psychiatrist, “remarkably common…adolescence is a period of life that is normally marked by tumultuous changes in personality.”

And what was the first thing he did to capitalize on his winning his “Australian of the Year” award?  He demanded the Australian government hand over another $200 million to fund more of his centers where he can drug more children.  Worse, the government is entertaining the idea. Continue reading »

Tags: , , , , , , , , , , , , , , , , , , , ,

Feb 08

Tens of thousands of vulnerable dementia patients are being prescribed ‘chemical cosh’ drugs in hospital wards in a ‘scandalous abuse’ of the elderly, ten leading health organisations have said in a letter to The Daily Telegraph.

woman_pills_001
Alzheimer’s patients with diabetes experience slower decline in memory, surprise research findings suggest. Photo: GETTY

Three quarters of nurses have seen people with dementia in general wards in hospital prescribed antipsychotic drugs that are known to double the risk of death and triple the risk of a stroke in these patients, research has shown.

It is the first time the scale of the abuse in hospital wards is exposed, following warnings that 100,000 dementia patients in care homes are prescribed the drugs leading to the deaths of 23,000 a year.

Ten leading charities, carers groups and experts have written to The Daily Telegraph saying: “We cannot stand by while this scandalous abuse of vulnerable citizens continues.”

Neil Hunt, Chief Executive of Alzheimer’s Society said: “The massive over prescription of antipsychotics to people with dementia is an abuse of human rights, causing serious side effects and increasing risk of death. These powerful drugs should only be used in a small number of cases. The Government must take action to ensure that these drugs are only ever used as a last resort.”

They have called on the government to publish its long-overdue review of the use of antipsychotics which ministers promised would be out in May of this year.

Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, said: “While the Department of Health prevaricates, thousands of people are being put at risk through the misuse of antipsychotics.”

There are 700,000 people in Britain with dementia and the numbers are rising rapidly.

Antipsychotics have a sedative effect and are not licensed for use in dementia but are prescribed when patients become agitated or difficult and often then are left on them for long periods.

A survey by the Alzheimer’s Society of over 1,000 nurses and nurse managers working on general wards in hospitals found more than three quarters said antipsychotics were used always or sometimes and one quarter said that the drugs were used inappropriately. Continue reading »

Tags: , , , , , , ,

Dec 18

“Company documents publicized in federal court demonstrate that AstraZeneca Plc. knew about the risks associated with Seroquel as far back as 2000. Currently, AstraZenca Plc. facing more than 15,000 consumer claims alleging the antipsychotic drug Seroquel causes diabetes.
Source: Alliance For Human Research Protection

See also: A Silenced Drug Study Creates An Uproar (Washington Post)


seroquel-astrazeneca

(NaturalNews) A federal lawsuit has been filed against pharmaceutical giant AstraZeneca for its role in paying Chicago psychiatrist Dr. Michael Reinstein nearly $500,000 over the course of a decade to conduct research and to promote its anti-psychotic drug, Seroquel. Reinstein is being accused of wrongfully preying on thousands of mentally-ill patients in order to rake in profits for AstraZeneca.

Reinstein has a long history of working with AstraZeneca, receiving regular payments for speeches he would make across the country promoting the drug. AstraZeneca was also paying a for-profit research company, Uptown Research Institute, who in turn was paying Reinstein consulting fees for his services.

Cited in the lawsuit was the fact that Reinstein would continually prescribe roughly double the amount of drugs other psychiatrists would prescribe for the same conditions. When patients would report their pain and suffering due to the tremendous side effects of such drugs and their abnormally high dosages, Reinstein would largely ignore their concerns.

Other accusations include illegitimately prescribing Seroquel for various other conditions, including losing weight, despite the fact that studies show the drug actually causes weight gain. Reinstein was found to have made numerous false claims about Seroquel in promotional material, claims that would result in the destruction of people’s lives and health.

When all was said and done, more than 1,000 patients a year received Seroquel prescriptions from Reinstein at a cost of $7.6 million to taxpayers. It is unknown how many billions of dollars AstraZeneca has made from the widespread efforts of Reinstein in promoting the drug nationwide for all those years.

Continue reading »

Tags: , , , , , , ,

Jun 14

The documents also revealed Lilly officials wrote medical journal studies about Zyprexa and then asked doctors to put their names on the articles, a practice called “ghostwriting.”

Lilly employees compiled a guide to hiring scientists to write favorable articles, complained to journal editors when publication was delayed and submitted rejected articles to other outlets, according to the documents.

Criminals!


The drug has never been approved for use with dementia patients, according to the FDA’s Web site.

zyprexa-eli-lilly
A file photograph of Eli Lilly & Co.’s schizophrenia medication, Zyprexa, in Cambridge, Massachusetts. Photographer: JB Reed/Bloomberg News

June 12 (Bloomberg) — Eli Lilly & Co. urged doctors to prescribe Zyprexa for elderly patients with dementia, an unapproved use for the antipsychotic, even though the drugmaker had evidence the medicine didn’t work for such patients, according to unsealed internal company documents.

In 1999, four years after Lilly sent study results to the U.S. Food and Drug Administration showing Zyprexa didn’t alleviate dementia symptoms in older patients, it began marketing the drug to those very people, according to documents unsealed in insurer suits against the company for overpayment.

Regulators required Lilly and other antipsychotic drug- makers in April 2005 to warn that the products posed an increased risk to elderly patients with dementia. The documents show the health dangers in marketing a drug for an unapproved use, called off-label promotion, said Sidney Wolfe, head of the health research group at Public Citizen in Washington.

“By definition, off-label means there is no clear evidence that the benefits of a drug outweigh the risks,” Wolfe said. “The reason why off-label promotion is illegal is that you can greatly magnify the number of people who will be harmed.”

In 1999, when Lilly began its marketing push, Zyprexa’s only approved use was for patients suffering from schizophrenia, according to the FDA. In 2008, Zyprexa was Lilly’s best-selling drug, with $4.7 billion in sales, while antipsychotics as a group topped U.S. drug sales last year, with $14.6 billion.

Seven Studies

In a request for a December 2003 meeting over a proposed label change, Lilly told the FDA that data from seven studies showed Zyprexa didn’t alleviate symptoms of Alzheimer’s or other dementia.

The studies found death rates among older dementia patients taking Zyprexa were “significantly greater” than those who didn’t get the medicine, the company said, according to the unsealed documents.

Continue reading »

Tags: , , , , , , , , , , , ,

Apr 09

· Anti-psychotics may cause long-term harm, say critics
· Youngsters under 6 being given unlicensed drugs

New evidence has shown children’s lives are being put at risk by a surge in the use of controversial tranquillising drugs which are being prescribed to control their behaviour, the Guardian has learned.

The anti-psychotic drugs are being given to youngsters under the age of six even though the drugs have no licence for use in children except in certain schizophrenia cases, the report says.

The number of children on the drugs has doubled since the early 1990s as the UK begins to follow a trend started in the US, but critics say they are a “chemical cosh” that could cause premature death. Continue reading »

Tags: , , , , , , , , , , , , ,